Sutro Biopharma Inc sell Bank of America Co.
Start price
14.03.25
/
50%
€0.85
Target price
14.03.26
€0.92
Performance (%)
-26.12%
End price
15.03.26
-
Summary
This prediction is currently being closed. The price of Sutro Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.12%. Bank_of_America_Co_ has a follow-up prediction for Sutro Biopharma Inc where he still thinks Sutro Biopharma Inc is a Sell. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sutro Biopharma Inc | - | - | - |
| iShares Core DAX® | -3.640% | -8.784% | -0.694% |
| iShares Nasdaq 100 | -2.986% | -1.710% | 11.948% |
| iShares Nikkei 225® | -3.000% | -9.097% | 23.387% |
| iShares S&P 500 | -2.389% | -2.781% | 7.620% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $1.00 price target on the stock, down previously from $11.00.
Ratings data for STRO provided by MarketBeat
In the thread Trading Sutro Biopharma Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€0.77
19.05.25
19.05.25
€0.72
19.05.26
19.05.26
-18.92%
02.12.25
02.12.25
